View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

AMN Healthcare Announces First Quarter 2024 Results

AMN Healthcare Announces First Quarter 2024 Results Quarterly revenue of $821 million; GAAP EPS of $0.45 and adjusted EPS of $0.97 DALLAS, May 09, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2024 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts.  Q1 2024% Change Q1 2023Revenue$820.9(27%) Gross profit$257.5(30%) Net income$17.3(79%) GAAP diluted EPS$0.45(78%) Adjusted dilute...

 PRESS RELEASE

Nordson Corporation Declares Third Quarter Dividend for Fiscal Year 20...

WESTLAKE, Ohio--(BUSINESS WIRE)-- (Nasdaq: NDSN) today announced that its board of directors declared a fiscal year 2024 third quarter cash dividend in the amount of $0.68 per common share, payable on June 4, 2024, to shareholders of record as of the close of business on May 21, 2024. This amount equals the $0.68 per common share dividend paid in the second quarter of fiscal year 2024. Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework through an entrepreneurial, division-led organization to deliver top tier growth with leading mar...

 PRESS RELEASE

Cytek Biosciences Reports First Quarter 2024 Financial Results

Cytek Biosciences Reports First Quarter 2024 Financial Results FREMONT, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the first quarter ended March 31, 2024. Recent Highlights Total revenue was $44.9 million, representing a 21% increase over the corresponding period of 2023 Organic revenue was $37.3 million, representing an increase of 11% compared to the first quarter of 2023First quarter revenue from the product lines acquired from Lumine...

Moody's Ratings assigns Baa2 rating to Hasbro's new senior unsecured n...

Moody's Ratings (Moody's) today assigned a Baa2 rating to Hasbro, Inc.'s ("Hasbro") new senior unsecured notes.  All other ratings, including the Baa2 senior unsecured and Prime-2 commercial paper ratings remain unchanged. The rating outlook is negative. The company plans to issue Benchmark of 10-...

 PRESS RELEASE

Keysight Designated Technical Service Provider for United Nations Auto...

SANTA ROSA, Calif.--(BUSINESS WIRE)-- (NYSE: KEYS), device security research lab, Riscure Security Solutions, has received formal approval from the Netherlands Vehicle Authority () to become a designated technical service provider for approval of the United Nations Economic Commission for Europe (UNECE) R155 and R156 regulations. Created by the World Forum for Harmonization of Vehicle Regulations (WP.29), the UNECE R155 and R156 regulations establish cybersecurity and software update requirements to strengthen the safety and security of automotive systems. outlines cybersecurity requiremen...

 PRESS RELEASE

Kornit Digital Reports First Quarter 2024 Results

Kornit Digital Reports First Quarter 2024 Results First quarter revenues of $43.8 million, in line with previous guidanceFirst quarter GAAP net loss of $13.2 million; non-GAAP net loss of $5.3 millionGenerated positive cash flow from operations for the first quarter of 2024Successfully concluded Apollo beta with all three customers and built a healthy pipelineSignificant interest from new and existing customers on the all-inclusive click (“AIC”) model ROSH-HA`AYIN, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- Kornit Digital Ltd. (“Kornit” or the “Company”) (Nasdaq: KRNT), a worldwide market ...

 PRESS RELEASE

Beam Therapeutics to Participate in RBC Capital Markets 2024 Global He...

Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, plans to participate in a fireside chat during the RBC Capital Markets 2024 Global Healthcare Conference on Wednesday, May 15, 2024, at 1:35 p.m. ET in New York City. A live webcast will be available in the investor section of the company's website at , and will be archived for 60 day...

Kellanova Co: 1 director

Two Directors at Kellanova Co sold 87,600 shares at between 60.052USD and 60.923USD. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...

 PRESS RELEASE

Keysight Introduces Pulse Generator Option for Handheld Analyzers

SANTA ROSA, Calif.--(BUSINESS WIRE)-- (NYSE: KEYS) has expanded the for its of handheld radio frequency (RF) analyzers to include a pulse generator. Available for B- and C-Series FieldFox handheld analyzers, the downloadable Option 357 pulse generator offers field engineers a diverse array of pulse types at frequencies up to 54 GHz. Field engineers conduct routine maintenance on and troubleshoot RF, microwave, and millimeter wave (mmWave) systems. During their work, they need to test a variety of devices and systems to ensure they are working as intended by using the data signals created ...

 PRESS RELEASE

Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Fina...

Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results Dosing Completed for Sentinel Cohort of BEACON Phase 1/2 Trial of BEAM-101 in Severe Sickle Cell Disease; Expansion Cohort Initiated Clinical Trial Authorisation (CTA) Application Cleared for the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency; Study to Initiate in First Half of 2024 BEAM-301 On Track for Submission of U.S. Investigational New Drug (IND) Application in First Half of 2024 Ended First Quarter 2024 with $1.1 Billion in Cash, Cash Equivalents and Marketable Securities; Cash Runw...

Moody's Ratings assigns Baa2 rating to Kellanova's proposed EUR notes

Moody's Ratings (Moody's) today assigned a Baa2 rating to Kellanova's proposed €300 million of 10-year senior unsecured notes. Kellanova's Baa2 senior unsecured ratings and Prime-2 commercial paper rating remains unchanged. The outlook is stable. Kellanova will utilize the net proceeds for general...

David Carlson ... (+4)
  • David Carlson
  • David Nierengarten
  • Dennis Pak
  • Martin Fan
Wedbush Research
  • Wedbush Research
TPX TEMPUR SEALY INTERNATIONAL INC
GEO GEO GROUP INC. (THE)
2454 MEDIATEK INC.
MTB M&T BANK CORPORATION
STZ CONSTELLATION BRANDS INC. CLASS A
UBI UBISOFT ENTERTAINMENT SA
QRVO QORVO INC.
DPZ DOMINO'S PIZZA INC.
WDC WESTERN DIGITAL CORPORATION
VRNS VARONIS SYSTEMS INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PEGA PEGASYSTEMS INC.
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
NCMI NATIONAL CINEMEDIA INC.
MU MICRON TECHNOLOGY INC.
MGPI MGP INGREDIENTS INC.
MFA MFA FINANCIAL INC.
INTC INTEL CORPORATION
IMAX IMAX CORPORATION
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FIS FIDELITY NATIONAL INFORMATION SERVICES INC.
FHN FIRST HORIZON CORPORATION
EPAM EPAM SYSTEMS INC.
DECK DECKERS OUTDOOR CORPORATION
CNK CINEMARK HOLDINGS INC.
CHKP CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AMC AMC ENTERTAINMENT HOLDINGS INC. CLASS A
OSTK OVERSTOCK.COM INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
HPE HEWLETT PACKARD ENTERPRISE CO.
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
CELH CELSIUS HOLDINGS INC.
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
AVGO BROADCOM INC.
TENB TENABLE HOLDINGS
GOSS GOSSAMER BIO
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
SMCI SUPER MICRO COMPUTER
ORIC INC.
TVTX ORIC PHARMACEUTICALS
PLTR TRAVERE THERAPEUTICS INC
DAWN PALANTIR TECHNOLOGIES
TDUP DAY ONE BIOPHARMACEUTICALS INC
MRVL THREDUP INC.
STX MARVELL TECHNOLOGY INC
HOWL SEAGATE TECHNOLOGY HLDGS PLC
PAY WEREWOLF THERAPEUTICS INC
GFS PAYMENTUS HLDGS INC
BROS GLOBALFOUNDRIES INC
DUTCH BROS INC
Valens Research
  • Valens Research

TWI - Valens Credit Report - 2024 03 28

Credit markets are materially overstating TWI's credit risk with a YTW of 7.338% relative to an Intrinsic YTW of 5.198% and an Intrinsic CDS of 99bps. Furthermore, Moody's is materially overstating TWI's fundamental credit risk with its highly speculative B1 credit rating five notches below Valens' IG4 (Baa2) credit rating. Incentives Dictate Behavior™ analysis highlights positive signals for creditors. TWI's metrics should generally drive management to focus on margins and turns, which could ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch